Robert Davis

Track

Insider profile

Currently holds a position at Integra Lifesciences Holdings Corp

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 96% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President, President - Orthopedics and Tissue Technologies Integra Lifesciences Holdings Corp Jan. 1, 2019 -
Corporate Vice President, President � Orthopedics and Tissue Technologies Integra Lifesciences Holdings Corp Dec. 1, 2016 - Jan. 1, 2019
Corporate Vice President, President - Specialty Surgical Solutions Integra Lifesciences Holdings Corp Nov. 1, 2014 - Dec. 1, 2016
Robert Davis's trades of Integra Lifesciences Holdings Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-08 2024-03-06
S Sale
1,362 -29.8%
137.19
US$4,412,561 		1,362 -29.8% 137.19 US$4,412,561
2024-03-06 2024-03-06
PrS Proposed sale
25,499
194.55
US$2,133,442 		25,499 194.55 US$2,133,442
2023-03-03 2023-03-01
S Sale
34,356 -20.5%
340.37
US$267,189 		34,356 -20.5% 340.37 US$267,189
2021-02-26 2021-02-25
S Sale
24,941 -55.8%
69.48
US$1,732,963 		24,941 -55.8% 69.48 US$1,732,963
2019-07-26 2019-07-24
PlS Planned sale
5,052 -11.9%
63.00
US$318,276 		5,052 -11.9% 63.00 US$318,276
2019-07-26 2019-07-24
PlS Planned sale
4,698 -11.2%
63.00
US$295,974 		4,698 -11.2% 63.00 US$295,974
2019-07-26 2019-07-24
PlS Planned sale
11,234 -23.2%
63.14
US$709,259 		11,234 -23.2% 63.14 US$709,259